Related Experiment Videos
Management of excessive anticoagulation or bleeding.
1Department of Haematology, Royal Hallamshire Hospital, Sheffield, United Kingdom. michaelmakris@hotmail.com
Seminars in Vascular Medicine
|June 17, 2004
Summary
Managing warfarin anticoagulation requires careful attention to bleeding risks. For severe hemorrhage, clotting factors are crucial, while vitamin K is preferred for less severe bleeding or high-risk patients.
Area of Science:
- Pharmacology
- Internal Medicine
- Hematology
Background:
- Warfarin anticoagulation has increased, leading to a rise in bleeding complications.
- Serious bleeding affects approximately 1% of patients, with a 0.5% annual mortality rate.
Purpose of the Study:
- To outline the complex management of hemorrhage in patients with excessive warfarin anticoagulation.
- To detail therapeutic interventions for immediate reversal and risk mitigation.
Main Methods:
- Review of current clinical practices for managing warfarin-induced bleeding.
- Balancing risks and benefits of anticoagulant reversal strategies.
Main Results:
- Clotting factor concentrates are essential for immediate reversal in life-threatening bleeding.
- Intravenous vitamin K is the primary treatment for less severe bleeding.
Conclusions:
- Vitamin K administration is indicated for overanticoagulated patients not actively bleeding but at high risk.
- Therapeutic strategies must be tailored to bleeding severity and patient risk factors.